Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestors
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
IONS
Ionis Pharmaceuticals, Inc. IONS
$73.14
โ–ผ -0.73% 24H
2.9023.8044.7065.6086.502001-072007-102014-012020-032026-06

About

Ionis Pharmaceuticals, Inc. is a biotechnology company specializing in the discovery, development, and commercialization of human therapeutics using antisense technology. This proprietary platform enables the creation of novel drugs targeting difficult-to-treat diseases across cardiovascular, metabolic, neurological, aโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees1,402
TickerIONS

Statistics

Market Cap$12.13B
Revenue (TTM)$943.7M
Net Income-$381.4M
Net Margin-40.4%
EPS$-2.01
P/E-31.01
P/S11.53
P/B24.92
EV/EBITDA-37.65
ROE-67.6%
Dividend Yieldโ€”
Price$73.14

Data: Twelve Data ยท Revenue = mcap / P/S

Ionis Pharmaceuticals, Inc. (IONS) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap